Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for GenMont Biotech Incorporation (3164.TW), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
21.19
P/B ratioShare price divided by book value per share.
1.11
P/S ratioMarket value divided by annual revenue.
3.82
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
14.80
EV / RevenueEnterprise value against annual revenue.
3.55
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
4.72%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
59.54%
Operating marginRevenue left after operating costs.
14.22%
Net marginRevenue left after every cost, including tax and interest.
18.10%
Return on equityProfit as a percentage of shareholders’ equity.
4.26%
Return on assetsProfit as a percentage of total assets.
1.09%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
3.59
Quick ratioThe same, excluding inventory.
2.65
Debt to equityTotal borrowings against shareholders’ equity.
0.09
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$0.80
Book value per shareShareholders’ equity divided by shares outstanding.
$15.23
Shares outstandingShares currently issued.
86,010,364
Market capitalisationShare price times shares outstanding.
$1.46B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
EmployeesReported headcount.
147
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
4.72%
Payout ratioShare of profit paid out as dividends.
What is GenMont Biotech Incorporation's P/E ratio?
GenMont Biotech Incorporation (3164.TW) trades on a price-to-earnings ratio of 21.19.
What is GenMont Biotech Incorporation's return on equity?
GenMont Biotech Incorporation (3164.TW) reports a return on equity of 4.26%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does GenMont Biotech Incorporation carry?
GenMont Biotech Incorporation (3164.TW) has a debt-to-equity ratio of 0.09, which compares total borrowings with shareholders' equity.
What is GenMont Biotech Incorporation's profit margin?
GenMont Biotech Incorporation (3164.TW) keeps 18.10% of revenue as net profit after every cost, including tax and interest.